Zugriffe | |
---|---|
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis | 77 |
Oktober 2023 | November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis | 16 | 0 | 0 | 2 | 8 | 0 | 1 |
Zugriffe | |
---|---|
2020_Burmester_etal.pdf | 27 |